Outcomes of supraventricular tachycardia ablation: Results from the Singapore ablation and cardiac devices registry

Abstract

AbstractBackgroundThe Singapore Cardiac Databank was designed to monitor the performance and outcomes of catheter ablation. We investigated the outcomes of paroxysmal supraventricular tachycardia (PSVT)‐ablation in a prospective, nationwide, cohort study.MethodsAtrioventricular nodal re‐entrant tachycardia (AVNRT), atrioventricular re‐entry tachycardia (AVRT), or atrial tachycardia (AT)‐ablations in Singapore from 2010 to 2018 were studied. Outcomes include acute success, periprocedural‐complications, postoperative pacing requirement, arrhythmic recurrence and 1‐year all‐cause mortality.ResultsAmong 2260 patients (mean age 45 ± 18 years, 50% female, 57% AVNRT, 37% AVRT, 6% AT), overall acute success rates of PSVT‐ablation was 98.4% and increased in order of AT, AVRT, and AVNRT (p < .001). Periprocedural cardiac tamponade occurred in two AVRT patients. A total of 15 pacemakers (6 within first 30‐days, 9 after 30‐days) were implanted (seven AV block, eight sinus node dysfunction [SND]), with the highest incidence of pacemaker implantation after AT‐ablation (5% vs. 0.6% AVNRT vs. 0.1% AVRT, p < .001). Repeat ablations (0.9% AVNRT, 7% AVRT, 4% AT, p < .001) were performed in 78 (3.5%) patients and 13 (0.6%) patients died within a year of ablation. Among outcomes considered adjusting for age, sex, PSVT‐type and procedure‐time, AT was independently associated with 6‐fold increased odds of total (adjusted odds ratio [AOR] 6.32, 95% confidence interval [CI] 1.95–20.53) and late (AOR 6.38, 95% CI 1.39–29.29) pacemaker implantation, while AVRT was associated with higher arrhythmic recurrence with repeat ablations (AOR 4.72, 95% CI 2.36–9.44) compared to AVNRT.ConclusionsContemporary PSVT ablation is safe with high acute success rates. Long‐term outcomes differed by nature of the PSVT.